Predictive Oncology EBITDA 2010-2024 | POAI

Predictive Oncology ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Historical Chart (TTM)

Click on chart icon to view chart
Click on table icon to view table

Quarterly

Click on chart icon to view chart
Click on table icon to view table

Quarterly - YOY Change

Click on chart icon to view chart
Click on table icon to view table

Annual

Click on chart icon to view chart
Click on table icon to view table

Annual % Change

Click on chart icon to view chart
Click on table icon to view table
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$37.2B
Hims & Hers Health (HIMS)$15B
Tempus AI (TEM)$13.5B
Inspire Medical Systems (INSP)$5.3B
IRhythm Technologies (IRTC)$3.5B
Privia Health (PRVA)$3.1B
Enovis (ENOV)$2.5B
Clover Health Investments (CLOV)$2.3B
Azenta (AZTA)$2.1B
Schrodinger (SDGR)$1.9B
Omnicell (OMCL)$1.9B
Phreesia (PHR)$1.7B
10x Genomics (TXG)$1.5B
Butterfly Network (BFLY)$1B
Talkspace (TALK)$652M
Fulgent Genetics (FLGT)$531M
Standard BioTools (LAB)$517M
TruBridge (TBRG)$426M
Nyxoah SA (NYXH)$357M
Health Catalyst (HCAT)$338M
SOPHiA GENETICS SA (SOPH)$319M
Pulmonx (LUNG)$262M
American Well (AMWL)$191M
EUDA Health Holdings (EUDA)$102M
MDxHealth SA (MDXH)$88M
P3 Health Partners (PIII)$77M
111 (YI)$69M
CareCloud (CCLD)$63M
HeartBeam (BEAT)$58M
Outset Medical (OM)$50M